Surgical Treatment of Type 2 Diabetes Mellitus in <35 Body Mass Index (BMI)

NCT00996294 — Not applicable, Unknown, 50 participants, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Surgical Treatment of Type 2 Diabetes Mellitus in Patients With BMI <35 kg/m2 (Italian Title: "La Terapia Chirurgica Del Diabete Mellito di Tipo 2 Nel Paziente Con BMI Inferiore a 35 kg/m2")

RegistryNCT00996294
StatusUnknown
PhaseNot applicable
Study typeInterventional; non randomized, single group, masking: none, treatment
Enrollment50 (Actual)
SponsorIRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy (Other)
ConditionsType 2 Diabetes Mellitus, Bariatric Surgery, Biliopancreatic Diversion, Gastric Bypass
Interventionsbiliopancreatic diversion, gastric bypass (Procedure)
Datesstart 2007-11-01, primary completion 2009-10-01, completion 2013-10-01 (estimated), first posted 2009-10-16, last updated 2010-01-12
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
All trials for Type 2 Diabetes Mellitus All trials for Bariatric Surgery All trials of biliopancreatic diversion, gastric bypass

-Summary

Thirty type 2 diabetic patients will be submitted to biliopancreatic diversion and 20 to gastric bypass. Subjects will be monitored during a 5 year period to assess the effects of the operations on diabetes control.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
surgeryExperimentalProcedure: biliopancreatic diversion, gastric bypasspatients will be submitted to biliopancreatic diversion or gastric bypass
  • biliopancreatic diversion, gastric bypass (Procedure): biliopancreatic diversion consists of a distal gastrectomy with a long Roux-en-Y reconstruction, where the enteroenterostomy is placed 50 cm proximal to the ileocecal valve gastric bypass consists of creating a small proximal gastric pouch by division of the upper stomach, with reconstruction of the GI continuity by means of a Roux-en-Y loop

+Outcome measures

Primary outcomes

  • Diabetes control, define by FSG and HbA1c [1 year]

Secondary outcomes

  • Diabetes control defined by FSG and HbA1c [5 years]

+Eligibility

Sex: All, ages: 35 Years to 70 Years

Inclusion Criteria:

* Type 2 diabetes mellitus
* Duration of diabetes ≥ 3 years
* Poor glycemic control (i.e., HbA1c ≥ 7.5%) in spite of hypoglycemic therapy in accordance with good clinical practice (GCP)

Exclusion Criteria:

* Specific contraindication to obesity surgery or biliopancreatic diversion or gastric bypass
* Pregnancy
* Medical conditions requiring acute hospitalisation
* Severe diabetes complications or associated medical conditions \[such as blindness, end-stage renal failure (i.e. serum creatinine >2 mg/dl), liver cirrhosis, malignancy, chronic congestive heart failure (NYHA class III and IV)\]
* Recent (within preceding 12 months) myocardial infarction, stroke or TIA
* Unstable angina pectoris
* Psychological conditions which may hamper patient's cooperation
* Geographic inaccessibility
* Any condition which, in the judgment of the Investigator, may make risky the participation in the study or bias the results

+Locations (1)

FacilityCityCountryStatus
Ospedale San MartinoGenovaItaly

+Publications

  • Results publication: Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, Andraghetti G, Catalano M, Cordera R. Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35. Obes Surg. 2014 Jul;24(7):1036-43. doi: 10.1007/s11695-014-1206-1. PMID 24647849
  • Results publication: Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, D'Alessandro G, Parodi C, Weiss A, Andraghetti G, Catalano M, Cordera R. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study. Obes Surg. 2011 Jul;21(7):880-8. doi: 10.1007/s11695-011-0407-0. PMID 21541815
  • Results publication: Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M, Briatore L, D'Alessandro G, Andraghetti G, Cordera R. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011 Apr;253(4):699-703. doi: 10.1097/SLA.0b013e318203ae44. PMID 21475009

+Investigators

  • Nicola Scopinaro, MD, Principal investigator, Azienda Ospedaliera Universitaria "San Martino", Genova, Italy